University of Arizona Research Shows Drug Can Extend Survival Rates for Heart Failure Patients

TUCSON, Arizona, Oct. 9 [TNSmedicalresearch] -- The University of Arizona issued the following news release:

Blood pressure medication can prevent fluid retention and muscle wasting in heart failure.

Researchers at the University of Arizona College of Medicine - Phoenix have shown for the first time in preclinical studies that Aliskiren, a drug that inhibits the enzyme that regulates blood pressure, can delay the progression of congestive heart failure and lengthen surv . . .

To gain access to full content fill out the form below.

Information Request Form

I'd like more information
Sign me up for a free trial

Name:
Newspaper/Company:
Email:
Phone:
State:
Keywords or Areas of Interest:

Select Product(s) you are interested in:
Daily Federal Tipoffs for your City/State
Congressional Vote Chart
Federal Contract Awards
Federal Patent Awards
News Releases from Federal Agencies
News Releases from States
News Releases from Counties
News Releases from Cities
Golf Handicap site (FairwayFiles.com)

Filling out this form will generate a contact, by phone or e-mail, from a TNS editor. No automated information is provided. How would you like to be contacted: Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Teresa Joseph, 602/827-2657, teresajoseph@email.arizona.edu